tosyllysine chloromethyl ketone has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arata, Y; Fukazawa, H; Mizuguchi, J; Nakanishi, M; Utsunomiya, N | 1 |
1 other study(ies) available for tosyllysine chloromethyl ketone and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Differential sensitivity of anti-IgM-induced and NaF-induced inositol phospholipid metabolism to serine protease inhibitors in BAL17 B lymphoma cells.
Topics: B-Lymphocytes; Calcium; Immunoglobulin M; Inositol Phosphates; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Activation; Phosphatidylinositols; Protease Inhibitors; Receptors, Antigen, B-Cell; Serine Endopeptidases; Signal Transduction; Sodium Fluoride; Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone; Tumor Cells, Cultured | 1989 |